Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVpc Specialty Regulatory News (VSL)

Share Price Information for Vpc Specialty (VSL)

Share Price is delayed by 15 minutes
Get Live Data
10.75    -0.525 (-4.66%)
Bid:
10.75
Ask:
11.05
Spread: 0.30 (2.791%)
Market Cap: £29.91m
VSL Live PriceLast checked at - London Stock Exchange

Intraday Vpc Specialty Share Chart

Net Asset Value(s)

12 Jan 2026 16:01

RNS Number : 5748O
VPC Specialty Lending Invest. PLC
12 January 2026
Β 

12 January 2026

VPC Specialty Lending Investments PLC

(the "Company")

QUARTERLY NET ASSET VALUE

In the Quarterly Report for the Third Quarter of 2025, the Company referred to the merger of Whele, LLC ("Razor Group" or "Razor") and Infinite Commerce on 28 August 2025. Following the completion of that merger, business performance of the newly combined entity has been poorer than anticipated and it is expected that the year-end valuation of Razor will be substantially lower than disclosed as at 30 September 2025 (https://vpcspecialtylending.com/). This is expected to have a material adverse impact on the Company's NAV overall, which will be reflected in the NAV as at 31 December 2025. More details will be included in the Quarterly Report for the Fourth Quarter of 2025.

The information contained in this announcement is inside information and is price sensitive. The entity responsible for arranging for the release of this announcement on behalf of VSL is MUFG Corporate Governance Limited.

Β 

Enquiries

For further information, please contact:

VPC Specialty Lending Investments PLC Nick Campsie

Victory Park Capital

Gordon Watson

via Victory Park Capital (below)

info@vpcspecialtylending.com

About VPC Specialty Lending Investments PLC

VPC Specialty Lending Investments PLC (Company No. 9385218) is a UK listed investment trust focused on asset-backed lending to emerging and established businesses with the goal of building long-term, sustainable income generation. The Company identifies investment opportunities across various industries and geographies to offer shareholders access to a diversified portfolio of opportunistic credit investments originated by non-bank lenders with a focus on the rapidly developing technology-enabled lending sector.

Β 

This document is for information purposes only and is not an offer to invest. All investments are subject to risk. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision. The value of investments may fluctuate. Results achieved in the past are no guarantee of future results.

Β 

LEI: 549300UPEXC5DQB81P34

Β 

Β 

Β 

Β 

.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
NAVUUVVRNKUAAAR
Date   Source Headline
11th Mar 20195:23 pmRNSTransaction in Own Shares
8th Mar 20194:14 pmRNSTransaction in Own Shares
7th Mar 20191:09 pmRNSDirector/PDMR Shareholding
5th Mar 20195:29 pmRNSTransaction in Own Shares
1st Mar 20195:25 pmRNSTransaction in Own Shares
1st Mar 20199:33 amRNSTotal Voting Rights
28th Feb 20193:30 pmRNSMonthly Report
28th Feb 20193:30 pmRNSNet Asset Value(s)
28th Feb 20197:00 amRNSDividend Declaration
27th Feb 20195:06 pmRNSTransaction in Own Shares
26th Feb 20195:46 pmRNSTransaction in Own Shares
26th Feb 20197:00 amRNSQuarterly Letter
12th Feb 20195:12 pmRNSTransaction in Own Shares
12th Feb 201910:54 amRNSHolding(s) in Company
12th Feb 201910:53 amRNSHolding(s) in Company
5th Feb 20195:09 pmRNSTransaction in Own Shares
1st Feb 201910:01 amRNSTotal Voting Rights
29th Jan 20197:15 amRNSMonthly Report
29th Jan 20197:00 amRNSNet Asset Value(s)
28th Jan 20195:54 pmRNSAndrew Adcock
17th Jan 20195:14 pmRNSTransaction in Own Shares
16th Jan 20195:20 pmRNSTransaction in Own Shares
10th Jan 20195:21 pmRNSTransaction in Own Shares
3rd Jan 20195:16 pmRNSTransaction in Own Shares
2nd Jan 201910:48 amRNSTotal Voting Rights
28th Dec 20187:00 amRNSDirector/PDMR Shareholding
24th Dec 20187:15 amRNSMonthly Report
24th Dec 20187:00 amRNSNet Asset Value(s)
14th Dec 20187:00 amRNSDirector Responsibilities
6th Dec 20185:23 pmRNSTransaction in Own Shares
4th Dec 201812:42 pmRNSDirector/PDMR Shareholding
4th Dec 201810:10 amRNSDirector/PDMR Shareholding
3rd Dec 201812:36 pmRNSTotal Voting Rights
3rd Dec 20187:00 amRNSPortfolio Update
30th Nov 20185:26 pmRNSTransaction in Own Shares
29th Nov 20187:15 amRNSMonthly Report
29th Nov 20187:00 amRNSNet Asset Value(s)
28th Nov 20183:23 pmRNSHolding(s) in Company
27th Nov 20184:51 pmRNSTransaction in Own Shares
26th Nov 20185:15 pmRNSTransaction in Own Shares
14th Nov 20187:00 amRNSDividend Declaration
9th Nov 20185:11 pmRNSTransaction in Own Shares
8th Nov 20185:24 pmRNSTransaction in Own Shares
1st Nov 20187:00 amRNSDirector/PDMR Shareholding
30th Oct 20185:17 pmRNSTransaction in Own Shares
30th Oct 20187:02 amRNSQuarterly Letter
30th Oct 20187:01 amRNSMonthly Report
30th Oct 20187:00 amRNSNet Asset Value(s)
18th Oct 20185:33 pmRNSTransaction in Own Shares
15th Oct 20185:26 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.